clinicaltrialsarena3h
Tryptamine Therapeutics completes dosing in obesity trial of TRP-8803
Tryptamine Therapeutics (Tryp) has announced the completion of subject dosing in a Phase Ib clinical trial of TRP-8803, for ...
clinicaltrialsarena7h
New breast cancer combo sees success in New York trial
The Phase I trial of the combination therapy saw a an approximate 66% rate of near-complete remission in its cohort of breast ...
clinicaltrialsarena19h
Radiopharmaceutical trials face extra complexities due to nuclear red tape
As more companies are investigating radiopharmaceuticals, the complexities and red tape faced by sponsors are becoming more ...
clinicaltrialsarena8h
Gilead’s twice-yearly lenacapavir shows promise in HIV prevention trial
Gilead Sciences has announced the outcomes from the Phase III PURPOSE 2 trial evaluating lenacapavir for HIV prevention.